Actinium Pharmaceuticals Inc (ATNM)
1.865
+0.10
(+5.97%)
USD |
NYAM |
Nov 05, 16:00
1.865
0.00 (0.00%)
After-Hours: 18:18
Actinium Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2021
--
Maximum
Mar 2021
--
Average
--
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Rezolute Inc | -- |
| Moderna Inc | 0.00 |
| Perspective Therapeutics Inc | -- |
| Eli Lilly and Co | 2.185 |
| Cellectar Biosciences Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 89.86M |
| Total Liabilities (Quarterly) | 46.03M |
| Shareholders Equity (Quarterly) | 43.84M |